insightSLICE

Multiple Myeloma Market

Multiple Myeloma Market - Global Market Share, Trends, Analysis and Forecast 2023 - 2032
Frequently asked questions about this report

The global multiple myeloma market was worth US$ 19.5 billion in 2020.

The global multiple myeloma market is expected to register a CAGR of 4.1% forecast to 2031.

The global multiple myeloma market is estimated to surpass US$ 30.2 Billion by 2031.

Launching of medications each year and latest updates noted in drugs and biotechnological areas or enterprises are major aspects driving the multiple myeloma market development.

Based on type, the multiple myeloma market is segmented into Smouldering and Active.

Key multiple myeloma market players are Johnson & Johnson Services Inc, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Eagle Pharmaceuticals, Inc, Fresenius Kabi AG, Teva Pharmaceutical Industries Ltd and others.